Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2012
03/21/2012CN102379986A Chinese herbal medicament for treating Yin-Yang vital energy-blood deficiency and collapse
03/21/2012CN102379950A Preparation method of bee larva recuperated medicine
03/21/2012CN102379887A Cardiovascular disease treating medicament and preparation method and application thereof
03/21/2012CN102379883A Pharmaceutical composition of glycerin fructose injection
03/21/2012CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/21/2012CN101687800B Glucokinase activator
03/21/2012CN101622003B Therapeutic agent for ameliorating prognosis after lower limb amputation surgery
03/21/2012CN101555283B Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101491515B Use of paclitaxel in preparing medicine for preventing and treating idiopathic pulmonary fibrosis
03/21/2012CN101380451B Preparation method of no-alcohol type Liusheng Qushu liquid oral preparation
03/21/2012CN101277713B Composition for acceleration of type I collagen production
03/21/2012CN101229241B Application of Chinese traditional medicine compounds on preparing medicines promoting mesenchymal stem cells surviving in the body and cardioblast differentiation
03/21/2012CN101164543B Acyl pseudopeptides bearing a functionalised auxiliary spacer
03/21/2012CN101161246B New purpose of ginsenoside Rh2
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138353 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
03/20/2012US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
03/20/2012US8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
03/20/2012US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease.
03/20/2012US8138200 Compositions and methods for double-targeting virus infections and targeting cancer cells
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8138159 Composition for inhibiting function of human Flt3
03/20/2012US8138141 HMG1 antibody for treating inflammatory conditions
03/20/2012US8137969 Neural progenitor cells derived from embryonic stem cells
03/20/2012US8137934 Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene
03/20/2012US8137662 Proliferated cell lines and uses thereof
03/20/2012CA2515293C Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage
03/20/2012CA2472711C 2-acylaminothiazole derivative or salt thereof
03/20/2012CA2444463C Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/20/2012CA2405469C Integrin binding peptide derivatives
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/20/2012CA2393468C Tissue regenerative composition
03/20/2012CA2392453C Modulation of signal transduction
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/20/2012CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells
03/15/2012WO2012034068A1 Treatment of constipation-predominant irritable bowel syndrome
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012033162A1 Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
03/15/2012WO2012033149A1 Hetero ring-fused imidazole derivative having ampk activating effect
03/15/2012WO2012033101A1 Quinoxaline compound
03/15/2012WO2012033069A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012WO2012033016A1 Drug for treating tumor, antitumor agent, method for treating tumor and kit for treating tumor
03/15/2012US20120065398 Method for producing 3-amidinophenylalanine derivatives
03/15/2012US20120065250 siRNA Targeting Apolipoprotein B (APOB)
03/15/2012US20120065203 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
03/15/2012US20120065194 Use of cyproheptadine to treat organophosphate exposure
03/15/2012US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065131 Compositions and methods for topical application and transdermal delivery of an oligopeptide
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/15/2012US20120064154 Solid drug for oral use
03/15/2012US20120064101 Compounds and Methods Useful for Detection and Treatment of Cancer
03/15/2012US20120064074 Antigen binding domains
03/15/2012US20120064056 Dichloracetate in combination with clinically high levels of cardioprotective or hemodynamic drugs
03/15/2012US20120064042 Xeno-free generation of tissue-specific progenitor cells
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/15/2012US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012CA2811025A1 Hetero ring-fused imidazole derivative having ampk activating effect
03/15/2012CA2811001A1 Treatment of constipation-predominant irritable bowel syndrome
03/15/2012CA2810659A1 Quinoxaline compound
03/15/2012CA2810489A1 Prostaglandin d synthase inhibitory piperidine compounds
03/14/2012EP2428509A1 Human adam-10 inhibitors
03/14/2012EP2428217A1 Composition based on docosahexaenoic acid (dha) for use in the treatment of cystic fibrosis and non-alcoholic hepatic steatosis
03/14/2012EP2428215A1 An angiogenesis inducing agent comprising recombinant gelatin
03/14/2012EP2427494A1 Diagnostic biomarkers for fibrotic disorders
03/14/2012EP2427167A1 Method and composition for restoration of age-related tissue loss in the face or selected areas of the body
03/14/2012EP2202229B1 Novel preparation for external use
03/14/2012EP2141155B1 Prophylactic and/or therapeutic agent for hyperlipidemia
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012CN202161681U 脾经组织疾病的治疗装置 The therapeutic device spleen tissue disease
03/14/2012CN102378753A Plasminogen activator inhibitor-1 inhibitor
03/14/2012CN102378635A Recombinant human albumin-human granulocyte colony stimulating factor for the prevention of neutropenia
03/14/2012CN102372764A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus
03/14/2012CN102370967A Novel application of IL-1Ra (interleukin-1 receptor antagonist) and tumor treatment medicinal composition kit thereof
03/14/2012CN102370891A Method for authenticating dendrobium officinale by using HPLC fingerprint
03/14/2012CN102370800A Chinese herbal medicine for treating female spurious pregnancy
03/14/2012CN102370794A Chinese herbal medicine for treating night sweat due to yin deficiency
03/14/2012CN102370666A Special lyophilized water beetle powder for athletes, and preparation method thereof
03/14/2012CN102370665A Traditional Chinese medicinal composition and method for treating sweating of children
03/14/2012CN102370635A Application and preparation method of novel nardosinone
03/14/2012CN102370632A Application of SIRT1 micro-molecular inhibitor in preparation of medicines for treating or preventing caner and protein deacetylation related diseases
03/14/2012CN101627983B Medicinal composition for inhibiting angiogenesis and application thereof
03/13/2012US8133513 Solid preparation having improved solubility
03/13/2012US8133498 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
03/13/2012CA2586056C Aryloxy-substituted benzimidazole derivative
03/13/2012CA2515574C Aminophosphonic acid derivative, salt thereof, and modulator of s1p receptor
03/13/2012CA2503810C Therapeutic agent for fibromyalgia
03/13/2012CA2500236C Diagnosis of anorexia nervosa and bulimia nervosa using bdnf as a biological marker
03/13/2012CA2480468C Fredericamycin derivatives
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/13/2012CA2369074C Ether compounds, compositions, and uses thereof
03/13/2012CA2361806C Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
03/13/2012CA2328140C Method of inhibiting osteoclast activity
03/13/2012CA2326959C Treatments for spinal muscular atrophy
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 1564